Chemical and biological investigation of Indigofera ammoxylum (DC.) Polhill. red and white phenotypes through feature-based molecular networking.

Anti-inflammatory Cytotoxic Fabaceae Feature-based molecular networking Flavonoids Indigofera ammoxylum Phenotype

Journal

Phytochemistry
ISSN: 1873-3700
Titre abrégé: Phytochemistry
Pays: England
ID NLM: 0151434

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 13 09 2023
revised: 25 01 2024
accepted: 26 01 2024
medline: 18 3 2024
pubmed: 4 2 2024
entrez: 3 2 2024
Statut: ppublish

Résumé

Chemical investigation of ethyl acetate bark extracts of Indigofera ammoxylum red and white phenotypes led to the bio-guided isolation of four previously undescribed flavonoids, named (2S,3R)-3',7-dihydroxy-4',6-dimethoxyflavanol (1), (2S,3R)-6-methoxy-7-hydroxyflavanol (2), 2',3',7-trihydroxy-4',6-dimethoxyisoflavone (7) and 2',5' -dimethoxy-4',5,7-trihydroxyisoflavanone (8), along with 14 known compounds (3-6 and 9-18). The previously undescribed structures were characterized based on NMR, HRESIMS, UV and IR data. Published spectroscopic data were used to deduce the structure of the known compounds. Eleven of the 18 isolated metabolites were evaluated for anti-inflammatory activity and cytotoxic activity against human liver carcinoma cells and human colon and colorectal adenocarcinoma cells. All tested compounds showed an anti-inflammatory activity (IC

Identifiants

pubmed: 38309451
pii: S0031-9422(24)00042-6
doi: 10.1016/j.phytochem.2024.114005
pii:
doi:

Substances chimiques

Flavonoids 0
Flavonols 0
Flavanones 0
Plant Extracts 0
Anti-Inflammatory Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114005

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Elise Gerometta (E)

Laboratoire de Chimie et de Biotechnologie des Produits Naturels, Faculté des Sciences et Technologies, Université de La Réunion, St Denis, La Réunion, France. Electronic address: elise.gerometta@univ-reunion.fr.

Elnur Garayev (E)

Aix Marseille Université, Avignon Université, CNRS, IRD, IMBE, Marseille, France, Faculty of Pharmacy, Service of Pharmacognosy, Marseille, France. Electronic address: elnur.garayev@univ-amu.fr.

Gaëtan Herbette (G)

Aix-Marseille Université, CNRS, Centrale Marseille, FSCM, Spectropole, Campus de St Jérôme - Service 511, Marseille, France. Electronic address: gaetan.herbette@univ-amu.fr.

Arnaud Marvilliers (A)

Laboratoire de Chimie et de Biotechnologie des Produits Naturels, Faculté des Sciences et Technologies, Université de La Réunion, St Denis, La Réunion, France. Electronic address: arnaud.marvilliers@univ-reunion.fr.

Carole Di Giorgio (C)

Aix-Marseille Université, Avignon Université, CNRS, IRD, IMBE, Marseille, France, Faculty of Pharmacy, Service of Environmental Mutagenesis, Marseille, France. Electronic address: carole.di-giorgio@univ-amu.fr.

Patricia Clerc (P)

Laboratoire de Chimie et de Biotechnologie des Produits Naturels, Faculté des Sciences et Technologies, Université de La Réunion, St Denis, La Réunion, France. Electronic address: patricia.clerc@univ-reunion.fr.

Michel Frederich (M)

Université de Liège, Département de Pharmacie, Centre Interfacultaire de Recherche sur le Médicament (CIRM), Laboratoire de Pharmacognosie, Campus Du Sart-Tilman, Quartier Hôpital, Liège, Belgium. Electronic address: m.frederich@uliege.be.

Béatrice Baghdikian (B)

Aix Marseille Université, Avignon Université, CNRS, IRD, IMBE, Marseille, France, Faculty of Pharmacy, Service of Pharmacognosy, Marseille, France. Electronic address: beatrice.baghdikian@univ-amu.fr.

Isabelle Grondin (I)

Laboratoire de Chimie et de Biotechnologie des Produits Naturels, Faculté des Sciences et Technologies, Université de La Réunion, St Denis, La Réunion, France. Electronic address: isabelle.grondin@univ-reunion.fr.

Anne Gauvin-Bialecki (A)

Laboratoire de Chimie et de Biotechnologie des Produits Naturels, Faculté des Sciences et Technologies, Université de La Réunion, St Denis, La Réunion, France. Electronic address: anne.bialecki@univ-reunion.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH